Telix_Main_Logo (3).png
Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer
May 30, 2024 18:49 ET | Telix Pharmaceuticals Limited
TLX591 is an investigational anti-PSMA1 radio-antibody-drug conjugate (rADC) therapy being developed for the treatment of mCRPC, differentiated by a short two-week dosing regimen.Reported median...
ValOre Metals Corp. Announces Voting Results of Annual General Meeting
May 30, 2024 18:38 ET | ValOre Metals Corporation
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- ValOre Metals Corp. (“ValOre” or the “Company”); (TSX‐V: VO; OTCQB: KVLQF; Frankfurt: KEQ0) today announced the voting results of its...
newsweek+logo.png
Media Alert: Newsweek Senior Writer Available to Discuss Trump Verdict
May 30, 2024 18:30 ET | Newsweek
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- After deliberation, the verdict for the Trump hush-money trial is in. Newsweek’s Senior Writer, Katherine Fung, has been live in the courtroom since Day 1,...
Hydreight-02_horizontal-01 (1) (002).jpg
Hydreight Reports Record Topline(1) Revenue of $4.87M in Q1-2024 (YOY Increase of 33%)
May 30, 2024 18:30 ET | Hydreight Technologies Inc.
VANCOUVER, British Columbia and LAS VEGAS, May 30, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) ( TSXV: NURS )( OTCQB: HYDTF )( FSE: SO6 ), a fast-growing...
LD Logo.png
Lowey Dannenberg, P.C. is Investigating Masimo Corporation (NASDAQ: MASI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
May 30, 2024 18:27 ET | Lowey Dannenberg, P.C.
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Masimo Corporation (“Masimo”) (NASDAQ:...
Lifelong Labs Logo-01.png
Lifelong Labs Founder Greg Lindberg Shares His Favorite Classic Books for Inspiration and Timeless Wisdom
May 30, 2024 18:15 ET | Lifelong Labs
ORLANDO, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- In an era dominated by digital media and fleeting trends, the timeless value of classic literature stands as a beacon of wisdom and insight. Greg...
central1_logo.png
Central 1 reports 2024 first quarter financial results
May 30, 2024 18:05 ET | Central 1 Credit Union
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- Central 1 Credit Union (Central 1) today reported its first quarter performance reflecting strong financial results across business...
Jasper.png
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
May 30, 2024 18:05 ET | Jasper Therapeutics, Inc.
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...
PETRUS_LOGO.png
Petrus Resources Announces Monthly Activity Update
May 30, 2024 18:01 ET | Petrus Resources Ltd.
CALGARY, Alberta, May 30, 2024 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to announce the most recent version of the Company’s monthly activity...
NOVARTIS logo.jpg
Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
May 30, 2024 18:01 ET | Novartis Pharma AG
Patients treated with remibrutinib experienced improvements in weekly urticaria activity scores (UAS7) observed as early as Week 1 and sustained to 1 year (Week 52)1Remibrutinib, an oral Bruton’s...